Skip to content

Kaiser Permanente Northwest

Does Kaiser Permanente Northwest cover Zepbound for Weight Loss?

It depends on your benefits. Kaiser Permanente Northwest covers Zepbound for weight loss only when your plan includes that benefit and the policy requirements are met.

Policy document

  • Employer: Depends on your plan's benefit. See the qualification pathways below.

Earliest policy review June 5, 2026. How we verify · Check your exact plan

Full requirements: Zepbound for Weight Loss (1 plan type)

Applies to Employer plans.

Depends on your plan's benefit

Covered under the prescription drug benefit for weight loss ONLY for Kaiser Northwest members with coverage for medications used to treat weight loss. Others pay member cash price.

Qualification pathways

You can qualify through any one of these.

New Start - Chronic Weight Management (Adult)

All of:

  • Patient has a prescription drug insurance benefit that covers medications used to lose weight
  • No personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
  • Diagnosis for chronic weight management
  • Patient is 18 years of age or older
  • Patient's current weight and BMI documented within the last 30 days approximately
  • Patient is currently following a diet and exercise program
  • BMI ≥ 30 kg/m2 OR (BMI ≥ 27 kg/m2 AND at least one comorbidity: hypertension, diabetes, or hyperlipidemia)
  • Failed adequate trial (3-month) of at least two of the listed non-GLP-1 weight loss medications/combinations OR allergy/intolerance/contraindication to ALL of them
  • Failed minimum 6-month trial of semaglutide (Ozempic/Wegovy) followed by bariatric medicine chart review OR allergy/intolerance/contraindication to semaglutide

New Member Already on Medication - Chronic Weight Management/Obesity

All of:

  • Patient has a prescription drug insurance benefit that covers medications used to lose weight
  • Patient is using for chronic weight management/obesity

Documentation to bring

  • Documentation of prescription drug benefit coverage for weight loss medications
  • Documentation of no personal or family history of MTC or MEN 2
  • Diagnosis documentation for chronic weight management
  • Current weight and BMI documented within the last 30 days
  • Documentation of current diet and exercise program participation
  • BMI ≥ 30 kg/m2 or BMI ≥ 27 kg/m2 with documentation of qualifying comorbidity (hypertension, diabetes, or hyperlipidemia)
  • Documentation of failed adequate trial (≥3 months each) of at least two of: phentermine, diethylpropion, topiramate, Qsymia, Contrave; OR documentation of allergy/intolerance/contraindication to ALL listed therapies
  • Documentation of failed minimum 6-month trial of semaglutide (Ozempic/Wegovy) with bariatric medicine chart review supporting need to switch; OR documentation of allergy/intolerance/contraindication to semaglutide

Approval and renewal

  • Initial approval: 12 months
  • Renewal: every 12 months
  • Renewal: At least 5% weight loss from the starting weight.
  • Renewal: Patient must have achieved and maintained 5% or greater weight loss after starting tirzepatide (Zepbound). Updated weight and BMI must be recently documented. Initial criteria (prior therapy trials, BMI thresholds, comorbidities, rider requirement) are not re-verified at continuation.

Not covered when

  • Personal or family history of medullary thyroid carcinoma (MTC)
  • Personal or family history of Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • No weight loss prescription drug benefit

Policy note: Adequate trial is defined as a 3-month treatment duration. Intolerance excludes adverse drug reactions that are expected, mild in nature, resolve with continued treatment, and do not require medication discontinuation. The non-GLP-1 step therapy requirement does NOT apply to Medicare Part D patients or Washington Medicare patients (footnote **). The prior semaglutide step therapy requirement also does NOT apply to Medicare Part D patients or Washington Medicare patients. A separate pathway exists for new members entering KP already on the medication for chronic weight management (simplified criteria requiring only benefit verification and diagnosis).

Policy effective June 4, 2026 · verified June 5, 2026 · source: Kp Zepbound Nw En · View policy document (PDF)

Open on its own page →

If weight loss isn't covered on your plan

A prior authorization can't override a benefit exclusion. Ask Kaiser Permanente Northwest about a formulary exception.

Questions people ask
Does Kaiser Permanente Northwest cover Zepbound?
It depends on your benefits. Kaiser Permanente Northwest covers Zepbound for weight loss only when your plan includes that benefit and the policy requirements are met.
How long does a Zepbound approval last with Kaiser Permanente Northwest?
Weight Loss — Applies to Employer plans. Initial approval: 12 months. Renewal: every 12 months.
What does Kaiser Permanente Northwest require to renew Zepbound?
Weight Loss — Applies to Employer plans. At least 5% weight loss from the starting weight. Patient must have achieved and maintained 5% or greater weight loss after starting tirzepatide (Zepbound). Updated weight and BMI must be recently documented. Initial criteria (prior therapy trials, BMI thresholds, comorbidities, rider requirement) are not re-verified at continuation.
How current is this information?
The oldest review date among the policies on this page is June 5, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under Kaiser Permanente Northwest: Mounjaro, Ozempic, Wegovy

Zepbound under other plans: Molina Healthcare, Oregon Medicaid, Premera, Regence, Washington Medicaid, Alabama Medicaid, California Medicaid, Colorado Medicaid

All insurance plans · All medications

Summary of Kaiser Permanente Northwest's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.